Click here to download our corporate presentation
BIOPHYTIS is a biotechnology company created in 2006, specialising in diseases associated with aging, particularly those affecting muscular and visual functions.
Aging science
By understanding the relationship between natural active substances and degeneration processes BIOPHYTIS is able to identify families of substances capable of acting directly on the mechanism of the disease.
BIOPHYTIS has a portfolio of first-in-class drug candidates, at various stages of development, for treating certain indications of sarcopenia and AMD, for which there is currently no treatment.
22 October 2018

Interim results 2018 and perspective on activity. Read the Press Release

10 October 2018

Interview with Stanislas Veillet, CEO of Biophytis, at the European Large & Midcap Event, Paris. Watch the video